107. 若年性特発性関節炎 Juvenile idiopathic arthritis Clinical trials / Disease details

臨床試験数 : 447 / 薬物数 : 297 - (DrugBank : 57) / 標的遺伝子数 : 52 - 標的パスウェイ数 : 146

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03301883 (ClinicalTrials.gov)	April 26, 2018	21/9/2017	A Study of Tocilizumab in Chinese Participants With Systemic Juvenile Idiopathic Arthritis (sJIA)	A Phase IV, Multicenter, Single-Arm, Open-Label Study to Assess the Efficacy and Safety of Tocilizum ...	Juvenile Idiopathic Arthritis	Drug: Tocilizumab;Drug: NSAIDs;Drug: CSs;Drug: MTX	Hoffmann-La Roche	NULL	Completed	2 Years	17 Years	All	62	Phase 4	China
2	NCT00688545 (ClinicalTrials.gov)	April 2009	29/5/2008	Naturalistic Safety Registry Of Celecoxib (CELEBREX(R)) And NSAIDs In Juvenile Idiopathic Arthritis	SINCERE™: Safety in Idiopathic Arthritis: NSAIDsand Celebrex Evaluation Registry A Prospective Obser ...	Arthritis, Juvenile Rheumatoid	Drug: Celecoxib;Drug: nsNSAIDs	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	NULL	Terminated	2 Years	17 Years	All	275		United States
3	NCT00642460 (ClinicalTrials.gov)	May 2008	19/3/2008	A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Systemic Juvenile Idiopathic Arth ...	A Randomized, Placebo-controlled Study to Evaluate the Effect of Tocilizumab on Disease Response in ...	Juvenile Idiopathic Arthritis	Drug: tocilizumab [RoActemra/Actemra];Drug: Placebo;Drug: Non-steroidal anti-inflammatory drugs (NSAI ...	Hoffmann-La Roche	NULL	Completed	2 Years	17 Years	All	112	Phase 3	United States;Argentina;Australia;Belgium;Brazil;Canada;Czech Republic;Denmark;Germany;Greece;Italy; ...

First Previous1Next Last